Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In a recent 2025 study using large-scale proteomic analysis of serum samples from two phase 3 clinical trials, Maretty et al
Hug G, McGraw CA, Bates SR, et al
ROS stimulate HSC activation, a key driver of liver fibrosis (Luangmonkong et al
This special will run from Wednesday November 19th through Monday December 1st
A systematic review published in eClinicalMedicine analyzed 18 randomized controlled trials involving 3,771 participants and found that discontinuing GLP-1 receptor agonists resulted in an average weight regain of 5.63 kg, along with an HbA1c increase of 0.25%
US$ 23.83
US$ 28.18
US$ 29.07
US$ 20.77
